SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB).

H. Amijee; Eugene O'Hare; E- Kim; D.I.C. Scopes; J.M. Treherne

SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB).

H. Amijee, Eugene O'Hare, E- Kim, D.I.C. Scopes, J.M. Treherne

Research output: Contribution to conference › Paper

Original language	English
Pages	000-000
Number of pages	1
Publication status	Published - Nov 2010
Event	Third Conference on Clinical Trials in Alzheimer's Disease - Toulouse, France Duration: 01 Nov 2010 → 01 Nov 2010

Conference

Conference	Third Conference on Clinical Trials in Alzheimer's Disease
Country/Territory	France
City	Toulouse
Period	01/11/2010 → 01/11/2010

Bibliographical note

Medium of Output: Conference Procedings

Cite this

Amijee, H., O'Hare, E., Kim, E., Scopes, D. I. C., & Treherne, J. M. (2010). SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB).. 000-000. Paper presented at Third Conference on Clinical Trials in Alzheimer's Disease, Toulouse, France.

@conference{92192b489cdb4655b18e7046c29c75ab,

title = "SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB).",

author = "H. Amijee and Eugene O'Hare and E- Kim and D.I.C. Scopes and J.M. Treherne",

note = "Medium of Output: Conference Procedings; Third Conference on Clinical Trials in Alzheimer's Disease ; Conference date: 01-11-2010 Through 01-11-2010",

year = "2010",

month = nov,

language = "English",

pages = "000--000",

}

Amijee, H, O'Hare, E, Kim, E, Scopes, DIC & Treherne, JM 2010, 'SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB).', Paper presented at Third Conference on Clinical Trials in Alzheimer's Disease, Toulouse, France, 01/11/2010 - 01/11/2010 pp. 000-000.

SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB). / Amijee, H.; O'Hare, Eugene; Kim, E- et al.
2010. 000-000 Paper presented at Third Conference on Clinical Trials in Alzheimer's Disease, Toulouse, France.

Research output: Contribution to conference › Paper

TY - CONF

T1 - SEN1269, a novel pyrrolo[3,2-e][1,2,4]trizolo1,5-a]pyrimidine inhibits AB-induced macrophage activation and protects against detrimental behavioural effects caused by fibrillar B-amyloid (AB).

AU - Amijee, H.

AU - O'Hare, Eugene

AU - Kim, E-

AU - Scopes, D.I.C.

AU - Treherne, J.M.

N1 - Medium of Output: Conference Procedings

PY - 2010/11

Y1 - 2010/11

M3 - Paper

SP - 0

EP - 0

T2 - Third Conference on Clinical Trials in Alzheimer's Disease

Y2 - 1 November 2010 through 1 November 2010

ER -